Welcome to Prospect - a support group for prostate cancer patients, their wives, partners and carers.
Prospect is run by prostate cancer survivors for the benefit of the communities in Bristol and surrounding districts

  • Next talk and a walk

    Our next BAWA meeting is on January 15, with a speaker (7pm). Directions on the right. The next walk will be on May 4 (details later). Coffee mornings are held at the Macmillan Centre, Southmead Hospital, on the first Thursday of each month (10am-12.30), to help new patients. Members needed to help out – contact our chairman on malcolmgamlin@gmail.com

  • New: Help improve cancer services

    Macmillan and North Bristol Trust are looking for cancer patients in North Bristol to help shape and improve local cancer services. A public meeting is being held on February 6 from 10-3pm at Garden Room, The Clifton Pavilion, Bristol Zoo Gardens, Clifton, Bristol BS8 3HA. Places are limited so book your place. There will be help with travel expenses, and there will be lunch and refreshments. If you can’t make it they still want to hear from you so get in touch. More info and to book a place contact VHodge@macmillan.org.uk or 01904 756443 (Dec ’17).

  • Big gift from golfers

    Victor Borg, seniors captain of Kendleshire Golf Club of 2017, nominated Prospect as his good cause of the year. The club seniors raised ÂŁ3,366.75 for our funds throughout the year, including a tournament in July. They presented the cheque to our chairman, Malcolm Gamlin, David Casley and Ken Head at their AGM on November 28. Grateful thanks to them.

  • Some treatment ‘unnecessary’

    Thousands of men with prostate cancer get risky treatment they don’t need. New approaches could curb that, it’s claimed (Nov ’17). See

  • Modified surgical technique

    A technique has been developed in which the surgeon approaches the prostate removal from under the bladder rather than above, possibly reducing the risk of incontinence. The Daily Mail report says this technique best suits those with a small prostate. It’s available privately and at certain hospitals on the NHS – including Southmead – if a man requests it. Some payment is involved. See

  • ‘Cure’ for terminal cancer

    Advanced radiotherapy could cure nearly three in four cases of terminal prostate cancer, it is claimed after a trial funded by Cancer Research UK. Researchers believe the technique could benefit thousands if available on the NHS. See. But newspapers’ claims are a little premature and have missed important points, say Prostate Cancer UK. Here they respond to the reports.

  • Southmead seeks help

    Southmead  Hospital has asked us for help to promote its appeal for funds to buy extra robotic surgery equipment. If you have had robotic surgery and would like to help by telling your story contact chairman Malcolm (malcolmgamlin@gmail.com). But beware of scammers making cold calls asking for funds in aid of the appeal. More information here.

  • Abiraterone ‘success’

    One of the largest clinical trials for prostate cancer has given “powerful results”, say UK researchers. Abiraterone, when used for treating prostate cancer that has spread, was found to save lives when offered earlier, a study found (June ’17). See

  • New blood test and PSA guidance

    A blood test that could one day be used to identify cancers that are resistant to abiraterone and enzalutamide has been developed by researchers funded by Prostate Cancer UK with support from the November Foundation (May ’17). See. And the government reissued guidance on the benefits and risks of PSA tests. The aim is to help primary care teams give men with no symptoms information about the potential benefits, limitations and implications of the test (Apr ’17). See.


  • Monitoring ‘wins’

    Active monitoring is as effective as surgery and radiotherapy, in terms of survival at 10 years, reports the largest study of its kind. The ProtecT trial was led by researchers at the Universities of Oxford and Bristol in nine UK centres. See

  • Alternative to biopsies?

    US researchers have developed a new way to capture cancer-derived particles called exosomes from prostate cancer, a finding that could offer an alternative to biopsies.  See. More news on the newsletter page.


A friendly and supportive network that aims to:

We have found that knowledge is of great benefit to the patient. It enables him to play an active part in the decision-making process, for example in selecting the best treatment.

We offer a friendly welcome – join us

Are you just diagnosed, or do you suspect that you may have prostate cancer? Then for friendly peer support and an introduction to Prospect email prospect.bristol@gmail.com or call the Tackle helpline, which will put you in touch with us:

0800 035 5302

This site has been compiled by prostate cancer survivors. We do not claim to have specialist knowledge other than that gained by prostate cancer patients during their treatment.

We give illustrated talks

Our Mike Broxton gives prostate cancer awareness talks to interested groups, including those with learning disabilities. To arrange a talk, contact prospect.bristol@gmail.com or 0800 035 5302.

Phone volunteers needed

Prostate Cancer UK needs more telephone support volunteers. This  service is provided by trained volunteers who support men affected by prostate cancer and their loved ones, by sharing their experiences of treatments. Apply at.

Having the conversation…

“Manversation” is a campaign to encourage men to speak about prostate cancer, particularly the advanced prostate form. Tackle have collaborated with Orchid, the male cancer charity, and put their name to a video and supporting material on the Manversation website.

Myths debunked

10 prostate cancer myths debunked. See

New information for at-risk black men

One in four black men will get prostate cancer – double the overall risk faced by all UK men. Are you are risk? See

Energise wins award

The exercise-based cancer rehab programme Energise won the Together We Achieve award for 2016. The award, announced at the inaugural Health & Care Awards in March, recognises teams working together to deliver improved patient care and public health. See a video about their work here. The classes are designed for people who have been affected by cancer and whose quality of life can be maintained or improved by taking part in regular, supervised exercise with cancer specialist instructors. Energise is a partnership between Macmillan, North Bristol NHS Trust, Sports Leisure Management Ltd and Bristol City Council. In a Bristol Post article on the Easton scheme participants tell how it helped them improve mood, vitality and well-being, and to overcome cancer-related fatigue. For more information on Energise see our Helpful links page.

Regional co-ordinator needed

Tackle need a Regional Co-ordinator for Western Counties to replace Sandy Tyndale-Biscoe of Cornwall. The holder acts as a focal point for communications on region-specific topics between the chairman, Roger Wotton, and member groups in the area. See. In addition, he or she will participate in occasional meetings or teleconferences. If any Prospect member would like to volunteer for this rewarding role, they can email roger.wotton@tackleprostate.org All expenses are reimbursed.

New research strategy launched

Prostate Cancer UK has launched an ambitious 10-year strategy setting out how it will invest in the most innovative research to create a step change in our knowledge of prostate cancer. See. And we have more research news here.

Swedish test shows promise

Swedish researchers found a test which is a potentially a game-changing step forward for prostate cancer risk assessment. It involved genetic and protein biomarkers (the S3M) and was much better than PSA alone at detecting potentially dangerous prostate cancers. The Swedish results give compelling evidence the S3M risk assessment model can dramatically cut the number of unnecessary biopsies, without compromising patients’ safety. But Prostate Cancer UK says it’s going to be important to validate this study in a more diverse population before it can accept that it will work elsewhere. It is funding more research to develop a new UK risk assessment tool. These plans are still going full steam ahead, and PCa UK expects to have more to say about this in 2017. See.

Tiger or pussycat? That’s the problem

It’s a big problem to tell the difference between slow-growing cancers and aggressive ones. See. But new research from one of Prostate Cancer UK’s Centres of Excellence could help identify which is which (Oct ’17). See

  • Know your risk

    Prostate Cancer UK has a new infographic and booklets.

    Exchange information

    www.myprostate.eu is now also available in English and prostate cancer patients can exchange information and help each other with treatment decisions.

  • Help with treatment choices

    Get enhanced guidance on treatment options, thanks to a checklist developed by researchers (Jun ’17). See. More help here. And why it’s difficult to choose among treatment options (Jul ’17). See. Men with early stage prostate cancer wishing to preserve sexual function while on treatment do not always make the right choices. See

  • Buddies offer home support

    This Macmillan service offers support for adult cancer patients in their homes in Bristol, North Somerset and South Gloucestershire for up to 12 weeks.

    Ring 07543 248714 or email bristolbuddies@macmillan.org.uk